ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Starpharma releases positive DEP® phase 2 interim results in prostate cancer
November 29, 2021Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel. -
Australian biotech company Starpharma announces positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel
November 29, 2021Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had efficacy responses, utilising one or more standard measures of disease.
Pharma Sources Insight January 2025
